299 related articles for article (PubMed ID: 36646004)
1. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.
Li T; Nickel B; Ngo P; McFadden K; Brennan M; Marinovich ML; Houssami N
Breast; 2023 Feb; 67():78-88. PubMed ID: 36646004
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis.
Ng JS; Hamilton DG
J Med Screen; 2022 Dec; 29(4):209-218. PubMed ID: 35593115
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area.
Solla Negrao EM; Cabello C; Conz L; Mauad EC; Zeferino LC; Vale DB
J Med Screen; 2023 Mar; 30(1):42-46. PubMed ID: 36071628
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
6. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
Tran C; Cipriano LE; Driman DK
CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
[TBL] [Abstract][Full Text] [Related]
8. A rapid review of COVID-19's global impact on breast cancer screening participation rates and volumes from January to December 2020.
Lee R; Xu W; Dozier M; McQuillan R; Theodoratou E; Figueroa J;
Elife; 2023 Sep; 12():. PubMed ID: 37698273
[TBL] [Abstract][Full Text] [Related]
9. Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic.
Adachi K; Kimura F; Takahashi H; Kaise H; Yamada K; Ueno E; Kawate T; Miyahara K; Ueda A; Sato S; Asaoka M; Okazaki M; Uenaka N; Orimoto K; Wu R; Koyama Y; Ishikawa T
Clin Breast Cancer; 2023 Apr; 23(3):265-271. PubMed ID: 36717319
[TBL] [Abstract][Full Text] [Related]
10. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
[TBL] [Abstract][Full Text] [Related]
11. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
Doan C; Li S; Goodwin JS
JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
[TBL] [Abstract][Full Text] [Related]
12. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study.
Bosch G; Posso M; Louro J; Roman M; Porta M; Castells X; Macià F
Elife; 2022 Jun; 11():. PubMed ID: 35686727
[TBL] [Abstract][Full Text] [Related]
14. Trends in breast, colon, pancreatic, and uterine cancers in women during the COVID-19 pandemic in North Carolina.
Nyante SJ; Deal AM; Heiling HM; Kim KS; Kuzmiak CM; Calhoun BC; Ray EM
Cancer Med; 2024 Apr; 13(7):e7156. PubMed ID: 38572934
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
16. The COVID-19 Pandemic Impact on Breast Cancer Diagnosis: A Retrospective Study.
Negrao EMS; Cabello C; Conz L; Mauad EC; Zeferino LC; Vale DB
Rev Bras Ginecol Obstet; 2022 Sep; 44(9):871-877. PubMed ID: 35667376
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 Pandemic on Histopathological Diagnosis of Breast Tumours in Calabar, Nigeria.
Udonkang M; Umoh N; Ogba O; Bebia G; Onwineng D; Anku B; Ernest N
Niger J Physiol Sci; 2023 Jun; 38(1):23-28. PubMed ID: 38243356
[TBL] [Abstract][Full Text] [Related]
19. Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients.
Triki M; Zghal M; Ayed HB; Makni S; Bouhamed M; Fendri S; Charfi S; Boudawara T; Mellouli M
Breast Dis; 2024; 43(1):9-17. PubMed ID: 38363601
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
Crivellaro P; Tafur M; George R; Muradali D
Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
